Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Goldman Sachs Group (NYSE: GS) | Delayed: 891.30 -13.42 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $904.72 | 52 Week High | $211.75 | |||
| Open | $884.92 | 52 Week Low | $138.20 | |||
| Day High | $906.35 | P/E | 57.65 | |||
| Day Low | $881.00 | EPS | $15.46 | |||
| Volume | 2,034,053 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||
